134 related articles for article (PubMed ID: 7025545)
21. Hypertension induced by adrenocortical dysfunction--hypertension in 17 alpha-hydroxylase deficiency and metopirone-induced hypertension.
Saruta T; Nakamura R; Saito I; Kondo K; Ohguro T; Yamagami K; Kitajima W; Oka M; Konishi K; Ozawa Y; Kato E; Matsuki S
Jpn Circ J; 1978 May; 42(5):621-31. PubMed ID: 212619
[TBL] [Abstract][Full Text] [Related]
22. Are there unknown mineralocorticoids in low-renin essential hypertension?
Hollifield JW; Slaton PE; Wilson HM; Sennett JA; Yarbro L; Island DP; Liddle GW
Mayo Clin Proc; 1977 May; 52(5):329-33. PubMed ID: 323587
[TBL] [Abstract][Full Text] [Related]
23. [Mineralocorticoid functional exploration in two cases of 11 beta OH corticosteroid deficiency].
Schaison G
Ann Endocrinol (Paris); 1974; 35(3):247-54. PubMed ID: 4377070
[No Abstract] [Full Text] [Related]
24. [Hyperaldosteronism sensitive to dexamethasone with adrenal adenoma. Clinical, biological and genetic study].
Jeunemaitre X; Charru A; Pascoe L; Guyene TT; Aupetit-Faisant B; Shackleton CH; Schambelan M; Plouin PF; Corvol P
Presse Med; 1995 Sep; 24(27):1243-8. PubMed ID: 7501605
[TBL] [Abstract][Full Text] [Related]
25. Excess mineralocorticoid receptor activity in patients with dexamethasone-suppressible hyperaldosteronism is under adrenocorticotropin control.
Speiser PW; Martin KO; Kao-Lo G; New MI
J Clin Endocrinol Metab; 1985 Aug; 61(2):297-302. PubMed ID: 2989319
[TBL] [Abstract][Full Text] [Related]
26. Mineralocorticoids, salt balance and blood pressure after prolonged ACTH administration in juvenile hypertension.
Rauh W; Levine LS; Gottesdiener K; New MI
Klin Wochenschr; 1978; 56 Suppl 1():161-7. PubMed ID: 215819
[TBL] [Abstract][Full Text] [Related]
27. Stress-induced Aldosterone Hyper-Secretion in a Substantial Subset of Patients With Essential Hypertension.
Markou A; Sertedaki A; Kaltsas G; Androulakis II; Marakaki C; Pappa T; Gouli A; Papanastasiou L; Fountoulakis S; Zacharoulis A; Karavidas A; Ragkou D; Charmandari E; Chrousos GP; Piaditis GP
J Clin Endocrinol Metab; 2015 Aug; 100(8):2857-64. PubMed ID: 25974737
[TBL] [Abstract][Full Text] [Related]
28. Clinical, biochemical and genetic approaches to the detection of familial hyperaldosteronism type I.
Stowasser M; Bachmann AW; Jonsson JR; Tunny TJ; Klemm SA; Gordon RD
J Hypertens; 1995 Dec; 13(12 Pt 2):1610-3. PubMed ID: 8903619
[TBL] [Abstract][Full Text] [Related]
29. Differing effects of metoclopramide and adrenocorticotropin on plasma aldosterone levels in glucocorticoid-suppressible hyperaldosteronism and other forms of hyperaldosteronism.
Ganguly A; Pratt JH; Weinberger MH; Grim CE; Fineberg NS
J Clin Endocrinol Metab; 1983 Aug; 57(2):388-92. PubMed ID: 6306041
[TBL] [Abstract][Full Text] [Related]
30. Mild adrenal 3 beta-hydroxysteroid dehydrogenase deficiency with hyperaldosteronism.
Hashimoto K; Makino S; Takao T; Sugawara M; Suemaru S; Ota Z
Endocrinol Jpn; 1988 Oct; 35(5):675-83. PubMed ID: 3220046
[TBL] [Abstract][Full Text] [Related]
31. Dexamethasone-suppressible hyperaldosteronism: pathophysiology, clinical aspects, and new insights into the pathogenesis.
Fallo F; Sonino N; Boscaro M; Armanini D; Mantero F; Dörr HG; Knorr D; Kuhnle U
Klin Wochenschr; 1987 May; 65(10):437-44. PubMed ID: 3037179
[TBL] [Abstract][Full Text] [Related]
32. Severity of hypertension in familial hyperaldosteronism type I: relationship to gender and degree of biochemical disturbance.
Stowasser M; Bachmann AW; Huggard PR; Rossetti TR; Gordon RD
J Clin Endocrinol Metab; 2000 Jun; 85(6):2160-6. PubMed ID: 10852446
[TBL] [Abstract][Full Text] [Related]
33. [Unilateral autonomous aldosterone production in hyperaldosteronism suppressible by dexamethasone].
Jakob F; Seufert J; Haack D; Schröder K; Ludwig J; Rendl J; Vecsei P
Dtsch Med Wochenschr; 1993 Dec; 118(50):1837-43. PubMed ID: 8269828
[TBL] [Abstract][Full Text] [Related]
34. Renin-aldosterone response to dexamethasone in glucocorticoid-suppressible hyperaldosteronism is altered by coexistent renal artery stenosis.
Stowasser M; Gordon RD; Klemm SA; Tunny TJ
J Clin Endocrinol Metab; 1993 Sep; 77(3):800-4. PubMed ID: 8396580
[TBL] [Abstract][Full Text] [Related]
35. Left ventricular mass in hereditary human hypertension: glucocorticoid-suppressible hyperaldosteronism.
Jamieson A; Murdoch D; Kennedy JA; Connell JM
J Hypertens; 1995 May; 13(5):551-6. PubMed ID: 7561013
[TBL] [Abstract][Full Text] [Related]
36. Primary hyperaldosteronism without suppressed renin due to secondary hypertensive kidney damage.
Oelkers W; Diederich S; Bähr V
J Clin Endocrinol Metab; 2000 Sep; 85(9):3266-70. PubMed ID: 10999820
[TBL] [Abstract][Full Text] [Related]
37. 19-nor-deoxycorticosterone excretion in primary aldosteronism and low renin hypertension.
Griffing GT; Dale SL; Holbrook MM; Melby JC
J Clin Endocrinol Metab; 1983 Feb; 56(2):218-21. PubMed ID: 6337172
[TBL] [Abstract][Full Text] [Related]
38. Volume-pressure relationships during development of mineralocorticoid hypertension in man.
Wenting GH; Man in 't Veld AJ; Verhoeven RP; Derkx FH; Schalekamp DH
Circ Res; 1977 May; 40(5 Suppl 1):I163-70. PubMed ID: 858175
[TBL] [Abstract][Full Text] [Related]
39. [Rectal electrical potential difference and plasma aldosterone in hyperaldosteronism and low-, normal- and high-renin hypertension].
Skrabal F; Mauser R
Wien Klin Wochenschr; 1976 Dec; 88(23):777-81. PubMed ID: 1014711
[TBL] [Abstract][Full Text] [Related]
40. Primary aldosteronism due to unilateral adrenal hyperplasia.
Ganguly A; Zager PG; Luetscher JA
J Clin Endocrinol Metab; 1980 Nov; 51(5):1190-4. PubMed ID: 6252233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
